Join
Live feed
·
INSIDERFilingvia Quantisnow
Denali Therapeutics Inc. logo

Chief Medical Officer Chin Peter Scott sold $36,868 worth of shares (1,654 units at $22.29), decreasing direct ownership by 0.80% to 204,538 units (SEC Form 4) to satisfy withholding tax

ByQuantisnow·Wall Street's wire, on your screen.
DNLI· Denali Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track DNLI (Denali Therapeutics Inc.) and more on Quantisnow.